Veranova: A CDMO that manages complexity with confidence.
01 1Veranova, L.P.
02 1Agno Pharma Jiangsu
03 1Apothecon Pharmaceuticals Pvt Ltd
04 1Aurobindo Pharma Limited
05 1Emcure Pharmaceuticals Limited
06 1Jiangsu Hengrui Pharmaceuticals Co., Ltd.
07 1MSN Laboratories Private Limited
08 1NATCO PHARMA LIMITED
09 1Piramal Pharma Solutions Inc.
10 1Zhejiang ChemPacific Corporation
01 2CARMUSTINE
02 8Carmustine
01 1China
02 5India
03 4U.S.A
Veranova: A CDMO that manages complexity with confidence.
NDC Package Code : 50137-0686
Start Marketing Date : 2014-06-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/1)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 57821-002
Start Marketing Date : 2018-06-06
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 76339-121
Start Marketing Date : 2019-09-06
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (4.999kg/4.999kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59651-168
Start Marketing Date : 2024-01-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59981-034
Start Marketing Date : 2016-03-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14593-823
Start Marketing Date : 2013-04-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (130g/130g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 57884-0032
Start Marketing Date : 2017-11-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (2kg/2kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54893-0055
Start Marketing Date : 2016-12-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 70225-1107
Start Marketing Date : 2020-02-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 58621-002
Start Marketing Date : 2020-12-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (100mg/30mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
17
PharmaCompass offers a list of Carmustine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Carmustine manufacturer or Carmustine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Carmustine manufacturer or Carmustine supplier.
PharmaCompass also assists you with knowing the Carmustine API Price utilized in the formulation of products. Carmustine API Price is not always fixed or binding as the Carmustine Price is obtained through a variety of data sources. The Carmustine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Gliadel Wafer manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Gliadel Wafer, including repackagers and relabelers. The FDA regulates Gliadel Wafer manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Gliadel Wafer API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Gliadel Wafer manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Gliadel Wafer supplier is an individual or a company that provides Gliadel Wafer active pharmaceutical ingredient (API) or Gliadel Wafer finished formulations upon request. The Gliadel Wafer suppliers may include Gliadel Wafer API manufacturers, exporters, distributors and traders.
click here to find a list of Gliadel Wafer suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Gliadel Wafer as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Gliadel Wafer API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Gliadel Wafer as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Gliadel Wafer and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Gliadel Wafer NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Gliadel Wafer suppliers with NDC on PharmaCompass.
We have 10 companies offering Gliadel Wafer
Get in contact with the supplier of your choice:
